Suppr超能文献

[分枝杆菌感染的实验室诊断]

[Laboratory diagnosis of mycobacterial infections].

作者信息

Martinez V, Gicquel B

机构信息

Unité de génétique des mycobactéries, Institut Pasteur, 75015 Paris, France.

出版信息

Arch Pediatr. 2005 Aug;12 Suppl 2:S96-101. doi: 10.1016/s0929-693x(05)80023-5.

Abstract

Every 10 seconds, one person in the world dies of tuberculosis (TB). It is estimated that one third of the world's population is latently infected with Mycobacterium tuberculosis. The proportion of multidrug-resistant strains of M. tuberculosis is increasing at an alarming rate in some parts of the world linked in part with the human immunodeficiency virus epidemic. For these reasons, TB remains a major public health problem, both in less-developed countries and in many industrialized countries, with 8-10 million new cases and 2 million deaths yearly in the world. Clinical, radiological and histological signs are not specific for tuberculosis or for other mycobacterial infections and allow only a presumptive diagnosis. In the same way, the tuberculin skin test is useful if the reaction is strong or phlyctenular because this test depends on various factors as previous BCG vaccination, contact or primary infection and host immune responses. The diagnosis of mycobacterial infection is proved only when bacilli are present in biological samples. Nevertheless, only 50% of cases in adults and 30% in infants have a positive bacteriological result. It seems necessary to develop new methods for a rapid and efficient diagnosis to optimize the therapy and the control of the epidemic. Laboratory testing in the mycobacterium field is experiencing more changes today than ever before. Determining what assays will be most useful to the clinician is a challenge, and acceptance of the new technology is under discussion. Progress in future will be linked probably to the progress of the genomic area. However the incidence rate is higher in less-developed countries, it is also important to develop now techniques possible to use in these countries. This review focuses on the current state-of-the-art resources useful for accurate and rapid laboratory diagnosis of mycobacterial infections.

摘要

世界上每10秒钟就有一人死于结核病(TB)。据估计,全球三分之一的人口潜伏感染结核分枝杆菌。在世界上一些地区,结核分枝杆菌多重耐药菌株的比例正以惊人的速度上升,这在一定程度上与人类免疫缺陷病毒流行有关。由于这些原因,结核病在欠发达国家和许多工业化国家仍然是一个重大的公共卫生问题,全球每年有800万至1000万新病例和200万人死亡。临床、放射学和组织学征象对结核病或其他分枝杆菌感染并无特异性,只能做出初步诊断。同样,结核菌素皮肤试验如果反应强烈或出现泡性反应则有用,因为该试验取决于多种因素,如既往卡介苗接种、接触或原发性感染以及宿主免疫反应。只有在生物样本中发现杆菌时,才能证实分枝杆菌感染的诊断。然而,成人病例中只有50%、婴儿病例中只有30%的细菌学检测结果呈阳性。开发快速有效的新诊断方法以优化治疗和控制疫情似乎很有必要。目前,分枝杆菌领域的实验室检测正在经历前所未有的变革。确定哪些检测方法对临床医生最有用是一项挑战,新技术的接受度也在讨论之中。未来的进展可能与基因组领域的进展相关。然而,尽管发病率在欠发达国家较高,但现在开发适用于这些国家的技术也很重要。本综述重点介绍了有助于准确快速实验室诊断分枝杆菌感染的当前先进资源。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验